Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Ong Tuyen Create: Alert

All | News | Filings
Date FiledTypeDescription
03/09/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
10/06/2021 4 Ong Tuyen (Director) has filed a Form 4 on Gemini Therapeutics, Inc. /DE
Txns: Granted 17,245 options to buy @ $3.8, valued at $65.5k
04/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2021 3 Ong Tuyen (Director) has filed a Form 3 on Gemini Therapeutics, Inc. /DE
06/07/2019 4 Ong Tuyen (Chief Development Officer) has filed a Form 4 on Nightstar Therapeutics plc
Txns: Disposed/sold 80,479 shares @ $25.5, valued at $2.1M
Disposed/sold 37,500 options to buy @ $14.24, valued at $534k
Disposed/sold 97,400 options to buy @ $14.74, valued at $1.4M
04/03/2019 4 Ong Tuyen (Chief Development Officer) has filed a Form 4 on Nightstar Therapeutics plc
Txns: Sold 2,446 shares @ $25.31, valued at $61.9k
01/24/2019 4 Ong Tuyen (Chief Development Officer) has filed a Form 4 on Nightstar Therapeutics plc
Txns: Granted 97,400 options to buy @ $14.74, valued at $1.4M
01/09/2019 4 Ong Tuyen (Chief Development Officer) has filed a Form 4 on Nightstar Therapeutics plc
Txns: Sold 2,546 shares @ $12.9808, valued at $33k
01/09/2019 4/A Ong Tuyen (Chief Development Officer) has filed a Form 4 on Nightstar Therapeutics plc
Txns: Sold 4,070 shares @ $12, valued at $48.8k
01/07/2019 4 Ong Tuyen (Chief Development Officer) has filed a Form 4 on Nightstar Therapeutics plc
Txns: Sold 4,070 shares @ $12, valued at $48.8k
01/02/2019 3 Ong Tuyen (Chief Development Officer) has filed a Form 3 on Nightstar Therapeutics plc
01/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
04/27/2016 3 Ong Tuyen (Chief Medical Officer) has filed a Form 3 on PTC THERAPEUTICS, INC.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy